Elon Musk’s brain implant company Neuralink says it has US approval to begin trials in people
Elon Musk's brain-implant company Neuralink on Thursday said it had received a green light from the U.S. Food and Drug Administration (FDA) to kickstart its first-in-human clinical study, a critical milestone after earlier struggles to gain approval.
Media Miss by the Right
See who else is reporting on this story and which side of the political spectrum they lean. To read other sources, click on the plus signs below.
Learn more about this dataLeft 28%
Center 44%
Right 29%
Bias Distribution
219 other sources covering this story
Total News Sources
219
Leaning Left
38
Center
60
Leaning Right
40
Last Updated
10 months ago